GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                            
                                
                                                                Synonyms: compound A-1 [WO2022023450]
                                 
                                                         
                            Compound class: 
                                                            Synthetic organic
                                 
                                
                                    
                                        Comment: The chemical structure for flezurafenib was obtained from proposed INN list 130 (Feb. 2024), in which the compound is described as a rapidly accelerated fibrosarcoma (Raf) kinase inhibitor with proposed antineoplastic action. It is one of the Raf inhibitors claimed in patent WO2022023450A1 [1]. Investigation of Jazz Pharmaceuticals' pipeline suggests that flezurafenib may be their oral pan-Raf inhibitor clinical lead JZP815. This lead is being explored for efficacy against solid tumours and haematologic malignancies harbouring oncogenic mutations that activate the RAS-RAF-MAPK pathway. We will update this entry when the structure for flezurafenib or JZP815 is publicly disclosed.
                                    
                                 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                    
                                    
                                     | 
                                    
                                        
                                         
  | 
                                    
                                
                                |||||||||||||||||||||||||||||||||||
Classification ![]()  | 
                                                    |
| Compound class | Synthetic organic | 
IUPAC Name ![]()  | 
                                                        
| 5-[[(3S)-3-[5-(4-fluorophenyl)-1H-imidazol-2-yl]-3,4-dihydro-2H-chromen-6-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one | 
International Nonproprietary Names ![]()  | 
                                                        |
| INN number | INN | 
| 12891 | flezurafenib | 
Synonyms ![]()  | 
                                                        
| compound A-1 [WO2022023450] | 
Database Links ![]()  | 
                                                        |
| CAS Registry No. | 2760321-00-2 (source: WHO INN record) | 
| GtoPdb PubChem SID | 491300015 | 
| PubChem CID | 162772363 | 
| Search Google for chemical match using the InChIKey | TWJSMWXWCWQPRO-QGZVFWFLSA-N | 
| Search Google for chemicals with the same backbone | TWJSMWXWCWQPRO | 
| Search PubMed clinical trials | flezurafenib | 
| Search PubMed titles | flezurafenib | 
| Search PubMed titles/abstracts | flezurafenib | 
| UniChem Compound Search for chemical match using the InChIKey | TWJSMWXWCWQPRO-QGZVFWFLSA-N | 
| UniChem Connectivity Search for chemical match using the InChIKey | TWJSMWXWCWQPRO-QGZVFWFLSA-N |